Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
L. Perrigo Company

L. Perrigo Company Recalls

All product recalls associated with L. Perrigo Company.

Get alerts for this brand

Recall Summary

Total Recalls

1000

Past Year

891

Class I (Serious)

124

Most Recent

Jan 2026

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 3181–3200 of 17593 recalls

Allergy Relief Tablets (Perrigo) – Impurities Spec Failure (2023)

Failed Impurities/Degradation Specifications

Class IIModerate

FDAFeb 9, 2023Nationwide• L. Perrigo Company

Fexofenadine Tablets (Perrigo) – Impurities Spec Failure (2023)

Failed Impurities/Degradation Specifications

Class IIModerate

FDAFeb 9, 2023Nationwide• L. Perrigo Company

Picnic Allergy Tablets (Perrigo) – Impurities Spec Failure (2023)

Failed Impurities/Degradation Specifications

Class IIModerate

1...158 159160161 162...880

Page 160 of 880Next

FDA

Feb 9, 2023

Nationwide

• L. Perrigo Company

Allergy Relief Tablets (Perrigo) – Impurities Spec Failure (2023)

Failed Impurities/Degradation Specifications

Class IIModerate

FDAFeb 9, 2023Nationwide• L. Perrigo Company

Non-Drowsy Allergy Relief (Perrigo) - Impurity Specifications (2023)

Failed Impurities/Degradation Specifications

Class IIModerate

FDAFeb 9, 2023Nationwide• L. Perrigo Company

ALLER-FEX Allergy Tablets (Perrigo) - Impurity Specifications (2023)

Failed Impurities/Degradation Specifications

Class IIModerate

FDAFeb 9, 2023Nationwide• L. Perrigo Company

Allergy Relief Tablets (Perrigo) – Impurities Spec Failure (2023)

Failed Impurities/Degradation Specifications

Class IIModerate

FDAFeb 9, 2023Nationwide• L. Perrigo Company

Fexofenadine Hydrochloride Tablets (Perrigo) - Impurity Specifications (2023)

Failed Impurities/Degradation Specifications

Class IIModerate

FDAFeb 9, 2023Nationwide• L. Perrigo Company

Allergy Relief Tablets (Perrigo) – Impurities Spec Failure (2023)

Failed Impurities/Degradation Specifications

Class IIModerate

FDAFeb 9, 2023Nationwide• L. Perrigo Company

Aller-Ease Allergy Tablets (Perrigo) - Impurity Specifications (2023)

Failed Impurities/Degradation Specifications

Class IIModerate

FDAFeb 9, 2023Nationwide• L. Perrigo Company

Allergy Relief Tablets (Perrigo) – Impurities Spec Failure (2023)

Failed Impurities/Degradation Specifications

Class IIModerate

FDAFeb 9, 2023Nationwide• L. Perrigo Company

myQ Garage Door Control Panels (Chamberlain) – entrapment risk (2023)

This recall involves LiftMaster myQ garage door control panels, sold individually or with wall-mount residential jackshaft garage door openers. LiftMaster and myQ are printed on the front of the black control panels. The recalled control panels were manufactured between March 2022 and October 2022. The manufacture date, in MM/YY format, the model number and the UPC code are printed on a label located on the back of the unit. The following are the model numbers and UPC codes included in this recall: Model Numbers UPC Codes 8500MC 012381203536 8500CMC 012381203529 8500RGDMC 012381203543 RJO20MC 012381188246 RJO20CMC 012381191277 RJO20CHMC 012381191277 889LMMC 012381203611 889RGDMC 012381203628 041A7928-3MC 012381204304

Moderate

CPSCFeb 9, 2023Nationwide• Grupo Chamberlain S.de R.L. de C.V., of Mexico

Medtronic Grafton Gel (Medtronic) – Packaging Concern (2023)

Potential for packaging non-conformances directly related to the dual-barrier, sterile pouch packaging system. Non-conforming packaging may lead to a breach in the sterile barrier.

Low

FDAFeb 8, 2023Nationwide• Medtronic Sofamor Danek USA Inc

Medtronic Grafton Orthoblend (Medtronic) – Packaging Concern (2023)

Potential for packaging non-conformances directly related to the dual-barrier, sterile pouch packaging system. Non-conforming packaging may lead to a breach in the sterile barrier.

Low

FDAFeb 8, 2023Nationwide• Medtronic Sofamor Danek USA Inc

Medtronic Grafton DBF Inject (Medtronic) – Packaging Concern (2023)

Potential for packaging non-conformances directly related to the dual-barrier, sterile pouch packaging system. Non-conforming packaging may lead to a breach in the sterile barrier.

Low

FDAFeb 8, 2023Nationwide• Medtronic Sofamor Danek USA Inc

Medtronic Grafton Crunch (Medtronic) – Packaging Concern (2023)

Potential for packaging non-conformances directly related to the dual-barrier, sterile pouch packaging system. Non-conforming packaging may lead to a breach in the sterile barrier.

Low

FDAFeb 8, 2023Nationwide• Medtronic Sofamor Danek USA Inc

Medtronic Accelerate Grafton DBF (Medtronic) – Packaging Concern (2023)

Potential for packaging non-conformances directly related to the dual-barrier, sterile pouch packaging system. Non-conforming packaging may lead to a breach in the sterile barrier.

Low

FDAFeb 8, 2023Nationwide• Medtronic Sofamor Danek USA Inc

Medtronic XPANSE Bone Insert (Medtronic) – Packaging Concern (2023)

Potential for packaging non-conformances directly related to the dual-barrier, sterile pouch packaging system. Non-conforming packaging may lead to a breach in the sterile barrier.

Low

FDAFeb 8, 2023Nationwide• Medtronic Sofamor Danek USA Inc

Medtronic Grafton Putty (Medtronic) – Packaging Concern (2023)

Potential for packaging non-conformances directly related to the dual-barrier, sterile pouch packaging system. Non-conforming packaging may lead to a breach in the sterile barrier.

Low

FDAFeb 8, 2023Nationwide• Medtronic Sofamor Danek USA Inc

Medtronic Grafton Matrix (Medtronic) – Packaging Concern (2023)

Potential for packaging non-conformances directly related to the dual-barrier, sterile pouch packaging system. Non-conforming packaging may lead to a breach in the sterile barrier.

Low

FDAFeb 8, 2023Nationwide• Medtronic Sofamor Danek USA Inc